Company: HURA
Filing Date: 2025-11-03
Form Type: S-3
Source: 0001193125-25-262843
Chunk: 46

Company: TuHURA Biosciences, Inc./NV
Filing Date: 2025-11-03
Form: S-3
Chunk 46
---
 privately negotiated transactions; |

| • |     | through the writing or settlement of options or other hedging transactions entered into after the effective date    
 of the registration statement of which this prospectus is a part, whether through an options exchange or otherwise; |

| • |     | broker-dealers may agree with the selling stockholders to sell a specified number of such shares at a stipulated 
 price per share;                                                                                                 |

| • |     | a combination of any such methods of disposition; and |

| • |     | any other method permitted pursuant to applicable law. |

The selling stockholders may also sell shares under Rule 144 under the Securities Act, if available, rather than under this prospectus. Upon our being notified in writing by the selling stockholders that any material arrangement has been entered into with a broker-dealer for the sale of the shares through a block trade, special offering exchange distribution or secondary distribution or a purchase by a broker or dealer, we will file a supplement to this prospectus, if required, pursuant to Rule 424(b) under the Securities Act, disclosing the method of distribution, the terms and conditions of the offering of such securities, including the offering price of the securities and the proceeds to the selling stockholders, if applicable, and any other required information. The selling stockholders also may transfer the shares of \Common Stock in other circumstances, in which case the transferees, pledgees or other successors in interest will be the selling beneficial owners for purposes of this prospectus. Offers to purchase the securities being offered by this prospectus may be solicited directly. Agents may also be designated to solicit offers to purchase the securities from time to time. If a dealer is utilized in the sale of the securities being offered by this prospectus, the securities will be sold to the dealer, as principal. The dealer may then resell the securities to the public at varying prices to be determined by the dealer at the time of resale. If an underwriter is utilized in the sale of the securities being offered by this prospectus, an underwriting agreement will be executed with the underwriter at the time of sale and the name of any underwriter will be provided in the prospectus supplement that the underwriter will use to make resales of the securities to the public. In connection with the sale of the securities, the selling stockholders or the purchasers of securities for whom the 35

underwriter may act as agent, may compensate the underwriter in the form of underwriting discounts or commissions. The under